Patents by Inventor Daniel Bischoff

Daniel Bischoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrical connector with minimal transfer of torsional load
    Patent number: 11923637
    Abstract: An electrical connector configured to be mated to a mating connector includes a housing assembly and a core assembly held rotatably within the housing assembly. The core assembly includes a contact assembly having a contact configured to electrically contact a mating contact of the mating connector, a finger protection assembly configured to at least partially cover the contact assembly, and a cable retention assembly configured to be attached onto an electrical cable.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: March 5, 2024
    Assignee: TE Connectivity Germany GmbH
    Inventors: Daniel Bischoff, Daniel Domke, Bjoern Schiemer
  • Crimp connection and crimp method for a crimp assembly with at least one retention shoulder
    Patent number: 11431113
    Abstract: A crimp assembly for electrically contacting a conductive component of an electrical cable includes an anvil bushing and a compression sleeve. The anvil bushing has a retention shoulder extending circumferentially on an outer peripheral surface of the anvil bushing and supporting a section of the conductive component. The compression sleeve has an inner diameter larger than an outer diameter of the retention shoulder.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: August 30, 2022
    Assignee: TE Connectivity Germany GmbH
    Inventors: Andreas Herrmann, Daniel Bischoff
  • Electrical Connector With Minimal Transfer of Torsional Load
    Publication number: 20220109270
    Abstract: An electrical connector configured to be mated to a mating connector includes a housing assembly and a core assembly held rotatably within the housing assembly. The core assembly includes a contact assembly having a contact configured to electrically contact a mating contact of the mating connector, a finger protection assembly configured to at least partially cover the contact assembly, and a cable retention assembly configured to be attached onto an electrical cable.
    Type: Application
    Filed: September 1, 2021
    Publication date: April 7, 2022
    Applicant: TE Connectivity Germany GmbH
    Inventor: Daniel Bischoff
  • Module for a high-current plug and/or a high-current cable, high-current plug, and method of influencing the EMC behaviour
    Patent number: 11258208
    Abstract: A module for a high-current plug and/or a high-current cable includes a coupling face coupling to a shield and an influencing device influencing an electromagnetic property of the shield.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: February 22, 2022
    Assignee: TE CONNECTIVITY GERMANY GMBH
    Inventors: Daniel Bischoff, Jens Koester, Mohammad Nikfal
  • Crimp Connection And Crimp Method For A Crimp Assembly With At Least One Retention Shoulder
    Publication number: 20210159615
    Abstract: A crimp assembly for electrically contacting a conductive component of an electrical cable includes an anvil bushing and a compression sleeve. The anvil bushing has a retention shoulder extending circumferentially on an outer peripheral surface of the anvil bushing and supporting a section of the conductive component. The compression sleeve has an inner diameter larger than an outer diameter of the retention shoulder.
    Type: Application
    Filed: November 19, 2020
    Publication date: May 27, 2021
    Applicant: TE Connectivity Germany GmbH
    Inventors: Andreas Herrmann, Daniel Bischoff
  • Module For A High-Current Plug And/Or A High-Current Cable, High-Current Plug, And Method Of Influencing The EMC Behaviour
    Publication number: 20200185864
    Abstract: A module for a high-current plug and/or a high-current cable includes a coupling face coupling to a shield and an influencing device influencing an electromagnetic property of the shield.
    Type: Application
    Filed: February 19, 2020
    Publication date: June 11, 2020
    Applicant: TE Connectivity Germany GmbH
    Inventors: Daniel Bischoff, Jens Koester, Mohammad Nikfal
  • Substituted quinolines and their use as medicaments
    Patent number: 9199937
    Abstract: Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: December 1, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Hoffmann, Daniel Bischoff, Georg Dahmann, Jasna Klicic, Gerhard Schaenzle, Stefan Ludwig Michael Wollin, Serge Gaston Convers-Reignier, Stephen Peter East, Frederic Jacques Marlin, Clive McCarthy, John Scott
  • Substituted Quinolines and Their Use As Medicaments
    Publication number: 20150065489
    Abstract: Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.
    Type: Application
    Filed: October 30, 2014
    Publication date: March 5, 2015
    Inventors: Matthias HOFFMANN, Daniel BISCHOFF, Georg DAHMANN, Jasna KLICIC, Gerhard SCHAENZLE, Stefan Ludwig Michael WOLLIN, Serge Gaston CONVERS-REIGNIER, Stephen Peter EAST, Frederic Jacques MARLIN, Clive McCARTHY, John SCOTT
  • Compounds
    Patent number: 8937176
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: January 20, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Rudolf, Daniel Bischoff, Georg Dahmann, Matthias Grauert, Raimund Kuelzer
  • Substituted quinolines and their use as medicaments
    Patent number: 8912173
    Abstract: Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: December 16, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Hoffmann, Daniel Bischoff, Georg Dahmann, Jasna Klicic, Gerhard Schaenzle, Stefan Ludwig Michael Wollin, Serge Gaston Convers-Reignier, Stephen Peter East, Frederic Jacques Marlin, Clive McCarthy, John Scott
  • Substituted triazoles useful as mGlu5 receptor modulators
    Patent number: 8889677
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 18, 2014
    Assignee: Boehringer Ingellheim International GmbH
    Inventors: Matthias Grauert, Daniel Bischoff, Georg Dahmann, Raimund Kuelzer, Klaus Rudolf
  • Compounds
    Patent number: 8846948
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3, R3a have meanings given in the description.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: September 30, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Rudolf, Daniel Bischoff, Georg Dahmann, Matthias Grauert, Raimund Kuelzer
  • N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
    Patent number: 8822464
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: September 2, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Grauert, Daniel Bischoff, Georg Dahmann, Raimund Kuelzer, Klaus Rudolf
  • Compounds
    Patent number: 8796467
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: August 5, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Rudolf, Daniel Bischoff, Georg Dahmann, Matthias Grauert, Raimund Kuelzer, Bernd Wellenzohn
  • Compounds
    Patent number: 8741892
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: June 3, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Grauert, Daniel Bischoff, Georg Dahmann, Raimund Kuelzer, Klaus Rudolf, Bernd Wellenzohn
  • Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity
    Patent number: 8716277
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: May 6, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Rudolf, Daniel Bischoff, Georg Dahmann, Matthias Grauert, Raimund Kuelzer, Bernd Wellenzohn
  • Compounds
    Patent number: 8642774
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: February 4, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Grauert, Daniel Bischoff, Georg Dahmann, Raimund Kuelzer, Klaus Rudolf, Bernd Wellenzohn
  • NOVEL COMPOUNDS
    Publication number: 20130184248
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.
    Type: Application
    Filed: January 11, 2013
    Publication date: July 18, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Matthias GRAUERT, Daniel BISCHOFF, Georg DAHMANN, Raimund KUELZER, Klaus RUDOLF
  • NOVEL COMPOUNDS
    Publication number: 20130158038
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.
    Type: Application
    Filed: December 10, 2012
    Publication date: June 20, 2013
    Inventors: Klaus RUDOLF, Daniel BISCHOFF, Georg DAHMANN, Matthias GRAUERT, Raimund KUELZER
  • NOVEL COMPOUNDS
    Publication number: 20130158011
    Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.
    Type: Application
    Filed: December 10, 2012
    Publication date: June 20, 2013
    Inventors: Klaus RUDOLF, Daniel BISCHOFF, Georg DAHMANN, Matthias GRAUERT, Raimund KUELZER, Bernd WELLENZOHN